The chairman of the investigational new drug (IND) committee in India is
A. Drug controller general of India, Government of India
B. Secretary, department of health research, Government of India
C. Directorate general of health sciences, Government of India
D. Secretary, department of biotechnology, government of India
Answer: Option A
This Question Belongs to Pharmacy >> Pharmaceutical Jurisprudence
Related Questions on Pharmaceutical Jurisprudence
In the D & C act the schedule relating to GMP is
A. Schedule M
B. Schedule T
C. Schedule S
D. Schedule
MRP of scheduled formulations = Ceiling Price +
A. Retail Price
B. Local Taxes as Applicable
C. None
D. All of the above
Join The Discussion